Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety study of adipose-derived mesenchymal stem cells for non-infectious corneal ulcer
jRCTa030260101Recruiting
- Sponsor
- Rohto Pharmaceutical Co., Ltd.
- Start
- Jul 2026
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of human adipose mesenchymal stem cells in corneal ulcer, sponsored by Rohto Pharmaceutical Co., Ltd. Primary endpoint: Safety. Started Jul 2026; status: recruiting.
02
Drugs
human adipose mesenchymal stem cells
03
Conditions
corneal ulcer
Beyond the preview
Go deeper on jRCTa030260101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTa030260101.